These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6098699)

  • 41. [Clinical studies on cefixime in pediatrics].
    Mikawa H; Mayumi M; Akiyama Y; Ito S; Watanabe Y; Kanaoka H; Takeshita S; Takahashi Y; Akiyama F; Yoshimura T
    Jpn J Antibiot; 1989 Dec; 42(12):2527-39. PubMed ID: 2693753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Fundamental and clinical studies on cefixime in pediatrics].
    Iwai N; Shibata M; Mizoguchi F; Nakamura H; Katayama M
    Jpn J Antibiot; 1986 Apr; 39(4):1087-105. PubMed ID: 3761539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical and pharmacokinetic evaluation of cefodizime in children].
    Hirabayashi Y; Higashino H; Kino M; Nobori U; Okazaki H; Kitamura N; Kobayashi Y
    Jpn J Antibiot; 1989 Jun; 42(6):1366-80. PubMed ID: 2795860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone].
    Fujii R; Meguro H; Arimasu O; Tagaya M; Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
    Jpn J Antibiot; 1986 Aug; 39(8):1988-2008. PubMed ID: 3540338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antibacterial potency of cefotiam based on the clinical effect, MIC and decrement of organisms in the sputum].
    Kawagoe M; Narushima K; Kitani A; Shibuya T; Hara M; Hosono K; Shitara M
    Jpn J Antibiot; 1983 Aug; 36(8):2053-7. PubMed ID: 6317912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Laboratory and clinical studies of cefmenoxime in the pediatric field].
    Nishimura T; Tabuki K; Hiromatsu K; Takashima T; Takagi M
    Jpn J Antibiot; 1982 Nov; 35(11):2535-44. PubMed ID: 6302335
    [No Abstract]   [Full Text] [Related]  

  • 47. [Fundamental and clinical studies on cefixime (5% granules) in the pediatric field].
    Toyonaga Y; Sugita M; Nakamura H; Joh K; Takahashi T; Kurosu Y; Hori M
    Jpn J Antibiot; 1986 Apr; 39(4):1055-75. PubMed ID: 3761537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections.
    Maslow MJ; Levine JF; Pollock AA; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1982 Jul; 22(1):103-7. PubMed ID: 6289735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ceftriaxone for the treatment of serious infections.
    Steele RW; Bradsher RW
    Am J Dis Child; 1983 Nov; 137(11):1044-7. PubMed ID: 6314805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical evaluation of cefixime in children].
    Meguro H; Arimasu O; Sohda H; Yoshida J; Togasaki K; Fujii R
    Jpn J Antibiot; 1986 Apr; 39(4):1007-19. PubMed ID: 3761534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effectiveness of cefotaxime in pediatric infectious diseases].
    Takimoto M; Tasaki T; Kusunoki Y; Yoshioka H; Hiramoto A; Sanae N; Tsuchida A; Maruyama S; Mukai N; Takahashi Y
    Jpn J Antibiot; 1985 Jan; 38(1):107-13. PubMed ID: 3989970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Fundamental and clinical study on ceftriaxone in the field of obstetrics and gynecology].
    Tsuji Y; Itoh K; Moriyama I; Ichijo M
    Jpn J Antibiot; 1984 Dec; 37(12):2371-6. PubMed ID: 6098731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ceftriaxone: in vitro studies and clinical evaluation.
    Gnann JW; Goetter WE; Elliott AM; Cobbs CG
    Antimicrob Agents Chemother; 1982 Jul; 22(1):1-9. PubMed ID: 6289734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical studies on cefotiam in pediatric infections (author's transl)].
    Okamoto K; Shino K; Fuke H; Watanabe K; Ozaki H
    Jpn J Antibiot; 1981 Jun; 34(6):1019-26. PubMed ID: 6270418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical experience with cefotiam in pediatric infections (author's transl)].
    Yanagisawa K; Ichihashi H
    Jpn J Antibiot; 1981 May; 34(5):705-10. PubMed ID: 6270412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Experimental and clinical studies on cefodizime in pediatrics].
    Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
    Jpn J Antibiot; 1989 Jun; 42(6):1322-35. PubMed ID: 2795856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ceftriaxone--clinical experience in the treatment of neonates.
    James J; Mulhall A; de Louvois J
    J Infect; 1985 Jul; 11(1):25-33. PubMed ID: 4031525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fundamental and clinical studies on cefmenoxime in the field of pediatrics].
    Toyonaga Y; Sugita M; Kawamura G; Kurosu Y; Horiuchi K; Hori M; Kohno S; Tatsusawa O; Takahashi T
    Jpn J Antibiot; 1982 Oct; 35(10):2423-39. PubMed ID: 6306294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.